cm338
mAbexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 11, 2021 (NCT05186285)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05775042 | Phase 2 | May 8, 2023 | Keymed Biosciences Co.Ltd, Peking University |
| NCT05371379 | Phase 1 | Jun 1, 2022 | Keymed Biosciences Co.Ltd |
| NCT05186285 | Phase 1 | Dec 11, 2021 | Keymed Biosciences Co.Ltd |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Keymed Biosciences Co.Ltd | For profit | 3 | 3 | 2 | 2021 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1